Collectively, these findings demonstrate that Rap2b palmitoylation promotes CRC metastasis through modulation of the AKT/GSK3β signaling pathway, and inhibiting palm-Rap2b using PTG-101 effectively suppresses CRC metastasis in vivo. Here, GSK3B is linked to colorectal carcinoma.